UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000047906
Receipt number R000054610
Scientific Title Electronic vaccination record as the basis of the next-generation electronic maternal and child health handbook
Date of disclosure of the study information 2022/05/31
Last modified on 2023/12/01 10:55:45

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Electronic vaccination record and its effectiveness

Acronym

Electronic vaccination record and its effectiveness

Scientific Title

Electronic vaccination record as the basis of the next-generation electronic maternal and child health handbook

Scientific Title:Acronym

Electronic vaccination record as the basis of the next-generation electronic maternal and child health handbook

Region

Japan


Condition

Condition

Vaccine Preventable Diseases

Classification by specialty

Child

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Using a PHR (personal health record) system that uses a card with a built-in IC chip for short-range wireless communication (NFC), we will verify the effect of suppressing vaccination errors in the field.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The number of electronic vaccination records and the number of vaccinations without error

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit

1 years-old >

Gender

Male and Female

Key inclusion criteria

Infants who live in Kawasaki-ku, Kawasaki City and have never been vaccinated at the time of recruitment

Key exclusion criteria

Infants scheduled to move out of Kawasaki-ku

Target sample size

1800


Research contact person

Name of lead principal investigator

1st name Masayoshi
Middle name
Last name Shinjoh

Organization

Keio University School of Medicine

Division name

Department of Pediatrics

Zip code

160-8582

Address

35 Shinanomachi, Shinjuku-ku, Tokyo, Japan

TEL

03-5363-3816

Email

m-shinjo@keio.jp


Public contact

Name of contact person

1st name Atsushi
Middle name
Last name Narabayashi

Organization

Kawasaki Municipal Hospital

Division name

Department of Pediatrics

Zip code

210-0013

Address

12-1 Shinkawadori, Kawasaki-ku, Kawasaki, Kanagawa, Japan

TEL

044-233-5521

Homepage URL


Email

naraba@2000.jukuin.keio.ac.jp


Sponsor or person

Institute

Keio University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Kanagawa Institute of Industrial Science and Technology

Organization

Division

Category of Funding Organization

Local Government

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Keio University School of Medicine

Address

35 Shinanomachi, Shinjuku-ku, Tokyo, Japan

Tel

N/A

Email

med-rinri-jimu@adst.keio.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 05 Month 31 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2020 Year 05 Month 08 Day

Date of IRB

2020 Year 05 Month 19 Day

Anticipated trial start date

2020 Year 09 Month 25 Day

Last follow-up date

2023 Year 03 Month 31 Day

Date of closure to data entry

2024 Year 03 Month 31 Day

Date trial data considered complete

2024 Year 03 Month 31 Day

Date analysis concluded

2025 Year 03 Month 31 Day


Other

Other related information

Registered an infant who lives in Kawasaki-ku, Kawasaki City and has never been vaccinated at the time of recruitment. Register until 2023/3/31.


Management information

Registered date

2022 Year 05 Month 31 Day

Last modified on

2023 Year 12 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000054610